Call us today 212-583-0100

Press Releases

Please view the latest press from Enzo Biochem, Inc.

Date Details
Monday, December 15, 2003 ENZO Biochem Reports Operating Results For Fiscal 2004 First Quarter
Thursday, November 06, 2003 ENZO Biochem Gene Vector for HIV Cleared to Begin Phase I/II Clinical Trial at New York Presbyterian Hospital-Weill Medical College of Cornell University
Wednesday, October 29, 2003 ENZO Biochem Reports Operating Results for Fiscal Year Ended July 31, 2003
Tuesday, October 28, 2003 ENZO Biochem Says Lawsuit Filed Against Affymetrix for Breach of Agreement
Monday, October 27, 2003 ENZO Biochem Develops New Therapeutic Platforms to Treat Immune-Mediated Diseases
Tuesday, September 16, 2003 ENZO Biochem Reports on Meeting in Israel
Monday, September 15, 2003 ENZO Biochem to Present at UBS Global Life Sciences Conference
Monday, June 16, 2003 ENZO Biochem Announces Third Quarter and Nine Months Operating Results. Board of Directors Declares 5% Stock Dividend.
Monday, June 09, 2003 ENZO Biochem Initiates Phase II Study of Crohn’s Disease Treatment.
Tuesday, May 20, 2003 ENZO Biochem Reports Phase I Clinical Trial Results of a New Mode of Crohn’s Disease Treatment. Seven of 10 Subjects Achieved Clinical Remission During Trial. ENZO to Initiate Phase II Study
Friday, March 14, 2003 ENZO Biochem Reports Continuing Growth in Second Quarter Operating Results
Monday, March 10, 2003 ENZO Biochem Announces Settlement with Two Companies in Patent Suit
Thursday, January 23, 2003 ENZO Biochem Tells Shareholders Meeting it Expects Further Progress in Operating Results and Product Development Plans
Wednesday, January 15, 2003 ENZO Biochem Comments on FDA Action

To view releases from previous years, select the year below that you would like to see. You may chose to view the latest news or reports dating back to 2003.